title: New cancer diagnostics and therapeutics from a ninth 'hallmark of cancer': symmetric self-renewal by mutated distributed stem cells.
abstract: A total of eight cellular alterations associated with human carcinogenesis have been framed as the 'hallmarks of cancer'. This representation overlooks a ninth hallmark of cancer: the requirement for tumor-originating distributed stem cells to shift sufficiently from asymmetric to symmetric self-renewal kinetics for attainment of the high cell production rate necessary to form clinically significant tumors within a human lifespan. Overlooking this ninth hallmark costs opportunities for discovery of more selective molecular targets for development of improved cancer therapeutics and missing cancer stem cell biomarkers of greater specificity. Here, the biological basis for the ninth hallmark of cancer is considered toward highlighting its importance in human carcinogenesis and, as such, its potential for revealing unique molecules for targeting cancer diagnostics and therapeutics.
authors.affiliation: The Adult Stem Cell Technology Center, P.O. Box 301179, Boston, MA 02130, USA.
authors.forename: James L
authors.initials: JL
authors.lastname: Sherley
mesh_terms: D060049:Asymmetric Cell Division; D063646:Carcinogenesis; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D009369:Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D014411:Neoplastic Stem Cells / Q000473:pathology* / Q000502:physiology; D014410:Tumor Stem Cell Assay